These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9776835)

  • 41. Effects of Pichia kluyveri killer toxin on sensitive cells.
    Middelbeek EJ; Stumm C; Vogels GD
    Antonie Van Leeuwenhoek; 1980; 46(2):205-20. PubMed ID: 7436405
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 2-dodecanol (decyl methyl carbinol) inhibits hyphal formation and SIR2 expression in C. albicans.
    Lim CS; Wong WF; Rosli R; Ng KP; Seow HF; Chong PP
    J Basic Microbiol; 2009 Dec; 49(6):579-83. PubMed ID: 19810039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The primary target of the killer toxin from Pichia acaciae is tRNA(Gln).
    Klassen R; Paluszynski JP; Wemhoff S; Pfeiffer A; Fricke J; Meinhardt F
    Mol Microbiol; 2008 Aug; 69(3):681-97. PubMed ID: 18532979
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antagonistic interplay of Swi1 and Tup1 on filamentous growth of Candida albicans.
    Mao X; Li Y; Wang H; Cao F; Chen J
    FEMS Microbiol Lett; 2008 Aug; 285(2):233-41. PubMed ID: 18564337
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 'Antibiobodies': antibiotic-like anti-idiotypic antibodies.
    Polonelli L; Conti S; Gerloni M; Magliani W; Castagnola M; Morace G; Chezzi C
    J Med Vet Mycol; 1991; 29(4):235-42. PubMed ID: 1941431
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pichia anomala and Kluyveromyces wickerhamii killer toxins as new tools against Dekkera/Brettanomyces spoilage yeasts.
    Comitini F; De Ingeniis J; Pepe L; Mannazzu I; Ciani M
    FEMS Microbiol Lett; 2004 Sep; 238(1):235-40. PubMed ID: 15336427
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemoglobin is utilized by Candida albicans in the hyphal form but not yeast form.
    Tanaka WT; Nakao N; Mikami T; Matsumoto T
    Biochem Biophys Res Commun; 1997 Mar; 232(2):350-3. PubMed ID: 9125179
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pichia acaciae killer system: genetic analysis of toxin immunity.
    Paluszynski JP; Klassen R; Meinhardt F
    Appl Environ Microbiol; 2007 Jul; 73(13):4373-8. PubMed ID: 17483256
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Unusual properties of the halotolerant yeast Candida nodaensis Killer toxin, CnKT.
    da Silva S; Calado S; Lucas C; Aguiar C
    Microbiol Res; 2008; 163(2):243-51. PubMed ID: 17761407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans.
    Messier C; Grenier D
    Mycoses; 2011 Nov; 54(6):e801-6. PubMed ID: 21615543
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A re-evaluation of the effect of cysteine or Candida albicans.
    Wain WH; Price MF; Cawson RA
    Sabouraudia; 1975 Mar; 13 Pt 1():74-82. PubMed ID: 1092000
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ultrastructural immunodetection of a Pichia anomala killer toxin: a preliminary study.
    Cailliez JC; Gerloni M; Morace G; Conti S; Cantelli C; Polonelli L
    Biol Cell; 1992; 75(1):19-23. PubMed ID: 1381254
    [TBL] [Abstract][Full Text] [Related]  

  • 53. First steps in the purification and characterization of a Pichia anomala killer toxin.
    Guyard C; Séguy N; Lange M; Ricard I; Polonelli L; Cailliez JC
    J Eukaryot Microbiol; 1999; 46(5):144S. PubMed ID: 10519293
    [No Abstract]   [Full Text] [Related]  

  • 54. Occurrence of killer yeast strains in industrial and clinical yeast isolates.
    Baeza ME; Sanhueza MA; Cifuentes VH
    Biol Res; 2008; 41(2):173-82. PubMed ID: 18949135
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of SMKT, a killer toxin produced by Pichia farinosa, with the yeast cell membranes.
    Suzuki C; Ando Y; Machida S
    Yeast; 2001 Dec; 18(16):1471-8. PubMed ID: 11748724
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monoclonal yeast killer toxin-like candidacidal anti-idiotypic antibodies.
    Polonelli L; Séguy N; Conti S; Gerloni M; Bertolotti D; Cantelli C; Magliani W; Cailliez JC
    Clin Diagn Lab Immunol; 1997 Mar; 4(2):142-6. PubMed ID: 9067647
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Killer toxin from several food-derived Debaryomyces hansenii strains effective against pathogenic Candida yeasts.
    Banjara N; Nickerson KW; Suhr MJ; Hallen-Adams HE
    Int J Food Microbiol; 2016 Apr; 222():23-9. PubMed ID: 26828815
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The costs and benefits of killer toxin production by the yeast Pichia kluyveri.
    Pintar J; Starmer WT
    Antonie Van Leeuwenhoek; 2003; 83(1):89-97. PubMed ID: 12755485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mycobactericidal activity of human natural, monoclonal, and recombinant yeast killer toxin-like antibodies.
    Conti S; Fanti F; Magliani W; Gerloni M; Bertolotti D; Salati A; Cassone A; Polonelli L
    J Infect Dis; 1998 Mar; 177(3):807-11. PubMed ID: 9498471
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Production and characterization of yeast killer toxin monoclonal antibodies.
    Polonelli L; Morace G
    J Clin Microbiol; 1987 Feb; 25(2):460-2. PubMed ID: 2434524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.